Business Wire

CORONA

23.7.2024 09:42:34 CEST | Business Wire | Press release

Share
Corona Cero Brings Same Seats as from Olympic Games Venues to Iconic Sunset Destinations Around the World

Today, Corona Cero, the global beer sponsor of the Olympic & Paralympic Games, unveils its Golden Venues activation, bringing the same seats as from the Olympic Games venues in Paris to iconic travel destinations across four continents. This initiative invites fans to reconnect with nature and gives them the opportunity to embrace their own Golden Moments every day as part of Corona Cero’s ‘For Every Golden Moment’ platform. This activation uses the same seats as from some of the Olympic Games venues in Paris, like Champ de Mars, Grand Palais, and Le Concorde and placed them in iconic travel destinations worldwide.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240722637366/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Greece - Corona Cero Golden Venues activation (Photo: Corona Cero)

The brand is featuring Golden Venues in 11 breath-taking outdoor settings across 9 countries, including renowned spots such as Arpoador beach in Rio de Janeiro, Brazil, the Grand Peninsula Lagonissi in Athens, Greece, and Café Del Mar in Cartagena, Colombia, offering panoramic views of their respective landscapes. The locations were selected for their remarkable sunsets, scenic beauty and cultural significance, offering visitors a unique opportunity to enjoy a touch of the Olympics amidst spectacular natural settings.

“From Greece, Brazil, Japan, South Africa and Argentina, Corona Cero is offering this gift to fans as an opportunity to experience the Olympic golden moment feeling through Golden Venues,” said Clarissa Pantoja, Vice President of Corona Global. “By bringing the same seats as from Olympic Games stadiums used throughout Paris to these incredible locations worldwide, we are reminding fans that golden moments not only exist within the Olympic Games, but also in the beauty of nature that’s around all of us.”

Corona, recognized as the world’s most valuable beer brand in Kantar’s BrandZ global 2024 rankings, has a rich history of promoting outdoor experiences and encouraging environmental stewardship. The brand is committed to fostering connections and creating meaningful moments in locations that resonate with fans globally.

The full list of Golden Venues spans:

Europe

  • Grand Peninsula Lagonissi in Athens, Greece, a popular beach and sailing destination on the Athenian Riviera with panoramic views of the Saronic Gulf;
  • Thames Riverfront in Battersea, London, UK, a bustling district with local and tourist attractions, including a riverside promenade, ecological areas, and sports facilities;

South America

  • Arpoador Beach in Rio de Janeiro, Brazil, next to Ipanema beach, this landmark destination is renowned for surfing and the best sunset views in town;
  • Café Del Mar in Cartagena, Colombia, located 150m high at the top of Old Town, Cafe Del Mar offers 360-views of Cartagena and is known for its stunning sunsets;
  • Coatepeque Volcano, El Salvador, a volcanic crater located 745 meters above sea level overlooking a 50,000 years old lake;
  • San Carlos de Bariloche, Argentina, a popular ski destination in the Argentinean Patagonia, surrounded by scenic forests and mountains;
  • Pichilemu in Punta de Lobos, Chile, a distinct beach with gray sand and large cliffs, Pichilemu is the heart of surf culture in Chile where many of the country's best surfers learned their skills;

Asia

  • Morito Beach in Kanagawa, Japan, known for its stunning views of Mt. Fuji, Morito Beach is one of the most famous spots on the coast of the Miura Peninsula;

Africa

  • South Africa (three locations) including Cape Town’s Signal Hill, offering panoramic views of V&A Waterfront, the Atlantic Ocean, Lion’s Head, and the iconic Table Mountain, one of the world's Seven Wonders of Nature.

“As the world anticipates the start of the Olympics, we are proud to see Corona Cero bring a touch of the Games to these global iconic locations for more fans to connect to their golden moments,” said Anne-Sophie Voumard, Managing Director IOC Television & Marketing Services. “We hope this gift will inspire people to embrace their own celebratory moments everyday!”

Fans can take in the beauty of nature while celebrating life’s golden moments – together with a refreshing Corona Cero served with a lime, or in any way they prefer to unwind and reconnect with nature. In select locations, the brand is also offering Sunset Hours, which are free concerts by local bands near the Golden Venues locations.

As the first-ever global beer sponsor of the Olympic Games, the no-alcohol beer brand is also elevating the role of moderation in Olympic celebrations globally, creating spaces and moments for cheers and choice in meaningful locations that matter to fans.

AB InBev brands have seen countless new friendships, connections, and experiences built on a shared love of sport and are pleased to be a part of that legacy with decades of historic, award-winning and responsible sports marketing.

The Golden Venues will be open to the public daily during the Olympic Games, starting July 23 with plans to remain in the area after the games.

###

About Corona Global
Corona, an AB InBev global brand*, is the iconic beer brand that is synonymous with paradise with a presence in 180 countries. Recognized as the world’s most valuable beer brand in Kantar’s BrandZ global 2024 rankings, Corona invites the world outside, beckoning you to reconnect with your essential nature and embrace the simple pleasures of life. But it's not just about the beer – it's about the ritual. The ritual of adding a slice of lime to your Corona, an experience that elevates the moment. Corona isn't just a beverage; it's nature in a bottle. And we strive to help protect nature and have become the first global beverage brand with a net-zero plastic footprint. This builds on our longstanding ambition to help protect the world’s oceans and beaches from plastic pollution. Every sip of Corona is a celebration of nature and the beauty of the world around us.

*Corona is not sold by AB InBev in the United States.

About The International Olympic Committee
The International Olympic Committee is a not-for-profit independent international organisation made up of volunteers, which is committed to building a better world through sport. It redistributes more than 90 per cent of its income to the wider sporting movement, which means that every day the equivalent of USD 4.25 million goes to help athletes and sports organisations at all levels around the world.

About AB InBev
AB InBev is a publicly traded company (Euronext: ABI) based in Leuven, Belgium, with secondary listings on the Mexico (MEXBOL: ANB) and South Africa (JSE: ANH) stock exchanges and with American Depositary Receipts on the New York Stock Exchange (NYSE: BUD). As a company, we dream big to create a future with more cheers. We are always looking to serve up new ways to meet life’s moments, move our industry forward and make a meaningful impact in the world. We are committed to building great brands that stand the test of time and to brewing the best beers using the finest ingredients. Our diverse portfolio of well over 500 beer brands includes global brands Budweiser®, Corona®, Stella Artois® and Michelob Ultra®; multi-country brands Beck’s®, Hoegaarden® and Leffe®; and local champions such as Aguila®, Antarctica®, Bud Light®, Brahma®, Cass®, Castle®, Castle Lite®, Cristal®, Harbin®, Jupiler®, Modelo Especial®, Quilmes®, Victoria®, Sedrin®, and Skol®. Our brewing heritage dates back more than 600 years, spanning continents and generations. From our European roots at the Den Hoorn brewery in Leuven, Belgium. To the pioneering spirit of the Anheuser & Co brewery in St. Louis, US. To the creation of the Castle Brewery in South Africa during the Johannesburg gold rush. To Bohemia, the first brewery in Brazil. Geographically diversified with a balanced exposure to developed and developing markets, we leverage the collective strengths of approximately 155,000 colleagues based in nearly 50 countries worldwide. For 2023, AB InBev’s reported revenue was 59.4 billion USD (excluding JVs and associates).

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240722637366/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Gurobi Appoints Dr. Pascal Van Hentenryck to Lead AI Innovation Lab17.2.2026 15:00:00 CET | Press release

Renowned optimization and AI technologies leader to advance hybrid approaches for demanding decision challenges. Gurobi Optimization, LLC, the leader in decision intelligence technology, is pleased to announce that Dr. Pascal Van Hentenryck has joined the company as head of the Gurobi AI Innovation Lab (GAIL). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260217170385/en/ Dr. Pascal Van Hentenryck, Head of AI Innovation Lab, Gurobi Optimization As part of Gurobi’s long-term product and technology strategy, the Gurobi AI Innovation Lab is a focused Research & Development initiative dedicated to advancing the combination of multiple AI technologies with optimization to solve complex, large-scale, and time-critical decision problems. “Pascal brings exceptional leadership across mathematical optimization and complementary AI technologies,” said Dr. Oliver Bastert, CTO, Gurobi Optimization. “While mathematical optimization remai

Esri and Pix4D Launch Real-Time Terrestrial Mapping Workflow17.2.2026 14:00:00 CET | Press release

Alliance Brings Seamless Integration of Asset Data into ArcGIS for PIX4Dcatch Users Pix4D joins with Esri to launch new terrestrial scanning workflow for infrastructure-focused organizations. Esri and Pix4D workflow lets field teams capture accurate 3D models and augmented reality using PIX4Dcatch app data integrated directly into ArcGIS Online in real time. New integration enables users to document subsurface assets with seamless precision. Workflow brings high-fidelity, georeferenced documentation and instant verification to the project lifecycle for improved accuracy. Explore the PIX4Dcatch app and publish 3D data to ArcGIS Online. Esri, the global leader in geographic information system (GIS) technology, has launched a terrestrial mapping workflow with Pix4D. A Switzerland-based photogrammetry software company, Pix4D specializes in mobile reality capture and site-digitization. The combined workflow allows field teams to capture and process asset data and manage it within ArcGIS, Es

Watchmaker Genomics Licenses CRISPR-Cas9 Intellectual Property from Caribou Biosciences to Increase Throughput and Reduce Sequencing Cost per Sample17.2.2026 14:00:00 CET | Press release

Watchmaker Genomics, an innovator in high-performance solutions for next-generation sequencing (NGS), today announced a non-exclusive license with Caribou Biosciences, Inc., a leading clinical-stage CRISPR genome-editing biopharmaceutical company, for certain foundational CRISPR-Cas9 intellectual property for use in NGS library preparation. While CRISPR-Cas9 technologies are most commonly associated with their unique ability to find and cut for genome editing, Watchmaker is leveraging it in a fundamentally different way: as a programmable, stoichiometric binding tool to address one of the most persistent and under-optimized steps in NGS workflows – library normalization. “Normalization has quietly become a bottleneck as sequencing throughput has scaled,” said Brian Kudlow, CSO and Founderat Watchmaker Genomics. “This license gives us the freedom to rethink normalization from first principles, using CRISPR-Cas9 in a way that’s orthogonal to editing but highly aligned with modern sequenc

Compass Pathways Successfully Achieves Primary Endpoint in Second Phase 3 Trial Evaluating COMP360 Psilocybin for Treatment-Resistant Depression17.2.2026 12:30:00 CET | Press release

Two highly statistically significant positive Phase 3 trials confirm highly differentiated profile for COMP360, demonstrating a level of clinical effect that has historically been extremely difficult to achieve in TRDCOMP360 is the first classic psychedelic1 to consistently achieve a highly statistically significant result and clinically meaningful effect, with a generally well-tolerated and safe profileIn COMP006, two doses of COMP360 25 mg versus 1 mg demonstrated a highly statistically significant and clinically meaningful reduction in symptom severity as measured by MADRS2 with a mean difference of -3.8 comparing 25 mg to 1 mg (p<0.001)3Clinically meaningful reduction in MADRS (≥ 25%) observed in significant number of participants in 25mg arm of both trials with 25% in COMP005 and 39% in COMP006Statistically significant rapid onset from the day following administration maintained at all measured timepoints through Week 6 in both clinical trials in the 25 mg armIn COMP005, participa

BeOne Medicines to Present at Upcoming Investor Conferences17.2.2026 12:00:00 CET | Press release

BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the Company will participate in fireside chats at four upcoming investor conferences: TD Cowen 46th Annual Health Care Conference on Monday, March 2, 2026 at 9:10 am ET; Leerink Global Healthcare Conference on Monday, March 9, 2026 at 11:20 am ET; Citizens Life Sciences Conference on Tuesday, March 10, 2026 at 9:35 am ET; and Barclays 28th Annual Global Healthcare Conference on Tuesday, March 10, 2026 at 3:00 pm ET Live webcasts of these events can be accessed from the investors section of the Company’s website at https://ir.beonemedicines.com. Archived replays will be available on the Company’s website. About BeOne Medicines BeOne Medicines is a global oncology company that is discovering and developing innovative treatments for cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel the

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye